CENTENNIAL, Colo., July 22, 2014 /PRNewswire/ -- Cochlear
Limited (ASX: COH), the global leader in implantable hearing
solutions, announced today that it is advocating against a newly
proposed Centers for Medicare & Medicaid Services (CMS) rule
that would change the classification of the Cochlear™ Baha® Implant
System under Medicare, treating it as a hearing aid subject to
exclusion from typically covered benefits. If adopted, the rule
would significantly limit access to this life changing technology
for Medicare patients and would interfere with the ability of
current Baha Implant System users on Medicare to maintain and
upgrade their equipment.
"After decades of struggling with hearing loss and trying
several sets of hearing aids, I decided I had to make a change,"
said Malcolm Simon, bilateral Baha
Implant System recipient. "I finally got smart and got my Baha
Implant System when I was 80 years old. I've since rediscovered
many things I used to enjoy, including going to church and
participating in volunteer activities. I owe my renewed spirit to
the support I received from CMS and want to ensure my peers have
similar access to the life changing technology that I am so
fortunate to enjoy."
By age 65, one out of three people has a hearing loss and by
that time, many people have already tried hearing aids, but report
never using them due to dissatisfaction with overall benefit,
comfort and performance in noise.1 For others, wearing a
hearing aid is simply not an option due to conditions such as
microtia and atresia (deformity or absence of the outer ear). For
these patients, the Baha Implant System is their only hope for
better hearing. The other alternative – untreated hearing loss – is
not recommended by experts and could lead to potentially damaging
consequences, including depression, decreased cognitive function
and even dementia.2,3
"In 2006, CMS correctly classified the Baha Implant System as a
prosthetic device which replaces the function of the middle ear and
cochlea. To date, the Baha Implant System has helped well over
100,000 people across the world and thanks to the coverage CMS has
provided, it has benefitted thousands in the United States alone," said Anthony Manna, President, Cochlear Bone Anchored
Solutions. "If the new proposal were to be accepted, the United States would be one of the very few
industrialized nations not to cover this life changing technology
for patients in need, for many of whom there is no alternative
treatment option and access to Baha Implant System technology is
most critical."
To support continued access to and coverage of the Baha Implant
System under Medicare:
- Sign a petition at
https://www.change.org/petitions/centers-for-medicare-medicaid-services-dept-of-health-human-services-continue-coverage-for-the-cochlear-baha-implant-system-a-life-changing-hearing-solution
- Submit comments to CMS via the official comment process by
August 29, 2014
- Visit
http://www.regulations.gov/#!documentDetail;D=CMS-2014-0092-0002
- Click 'Comment Now' in upper right hand corner
- Reference CMS-1614-P in your response
- Contact local Senators or Congressional Representatives
About the Baha Implant System
Designed to help people
with conductive hearing loss, mixed hearing loss and single-sided
deafness, the osseointegrated Baha Implant System utilizes the
body's natural ability to conduct sound. By connecting to the bone
behind the ear, the Baha Implant System replaces the function of
the outer or middle ear and sends sound directly to the healthy
inner ear. In people with single-sided deafness, sound is sent
through the bone to the hearing ear, bypassing the non-hearing
side. A physician must determine if a patient meets the candidacy
criteria for the Baha Implant System and deems the solution
medically necessary.
About Cochlear
Cochlear is the global leader in
implantable hearing solutions. It has a dedicated global team of
more than 2,700 people who deliver the gift of sound to those with
hearing loss in over 100 countries. Its vision is to connect
people, young and old, to a world of sound by offering life
enhancing hearing solutions.
The Cochlear promise of "Hear now. And always" embodies the
company's commitment to providing its recipients with their best
possible hearing performance today and for the rest of their lives.
For over 30 years, Cochlear has helped hundreds of thousands of
people either hear for the first time or reconnect them to their
families, friends, workplaces and communities.
For more information, visit www.Cochlear.com.
References
|
[ 1 ]
|
Hearing Loss
Association of America. Basic Facts About Hearing Loss. Available
at:
http://www.hearingloss.org/content/basic-facts-about-hearing-loss.
Accessed on July 15, 2014.
|
[ 2 ]
|
Kochkin, S., &
Rogin, C. M. A. (2000). Quantifying the obvious: The impact of
hearing instruments on quality of life [PDF, 5.5MB]. Hearing
Review, 7(1), 8–34.
|
[ 3 ]
|
Lin, F. R., Metter,
E. J., O'Brien, R. J., Resnick, S. M., Zonderman, A. B., &
Ferrucci, L. (2011). Hearing loss and incident dementia.
Archives of Neurology, 68, 214–220.
|
Logo -
http://photos.prnewswire.com/prnh/20130531/LA23942
SOURCE Cochlear Limited